Neal Foster

Neal is responsible for establishing the business strategy for the company, where he formed partnerships with leading, global pharma developers that have provided a foundation for the company’s growth. In addition to business, Neal is leading the execution of the software that is driving Gatehouse Bio’s platform.

As a serial intrapreneur, Neal has started new businesses within large organizations, and has led the technical diligence for mergers and acquisitions over $1B in value. Neal’s experience in building large scale ecosystems and complex commercial collaborations has led to creative partnerships that continue to drive growth within these companies.

Prior to co-founding Gatehouse Bio, Neal held executive leadership roles in Fortune 500 companies (NYSE: MSI, DELL, VMW, and NASDAQ: CMCSA), managing execution and sales for organizations focused on data-driven systems and software platforms.

Neal earned an MBA from the Wharton School of Business and a BS in computer and electrical engineering from Rutgers University. He earned dual certificates in Computational Biology and Precision Medicine from the Harvard Medical School. Neal holds 12 patents covering software architecture and complex data system design.